These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16410698)

  • 1. [Clinical administration of oxaliplatin for patients previously treated for refractory advanced or recurrent colorectal cancer].
    Takahari D; Tsuji Y; Sagawa T; Honda K; Sumiyoshi T; Yoshizaki N; Kuroiwa G; Kondo H
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):49-54. PubMed ID: 16410698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.
    Mosconi S; Cascinu S; Zaniboni A; Catalano V; Giordani P; Beretta GD; Martignoni G; Pancera G; Baldelli AM; Poletti P; Curti C; Labianca R
    Tumori; 2000; 86(6):465-9. PubMed ID: 11218187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical administration of FOLFOX regimens for patients with unresectable advanced or recurrent colorectal cancer].
    Minami K; Kameda A; Tsutani Y; Suzuki T; Miyahara E; Noso Y
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):573-7. PubMed ID: 17431362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
    Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
    Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
    Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A phase I study of modified FOLFOX 6 therapy for advanced colorectal cancer].
    Kojima S; Ina K; Futamura Y; Ito Y; Hibi S; Nagaoka M; Yuasa S; Kawai M; Nagao S; Kataoka T
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):203-6. PubMed ID: 17301527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of weekly low-dose CPT-11 combined with 5-FU/l-LV therapy for advanced and recurrent colorectal cancer--preliminary study].
    Tsubono M; Kaneko I; Kii E; Murata T; Deguchi Y; Sonoda K; Yasuda K
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1273-8. PubMed ID: 16969024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of 5-Fluorouracil and l-Leucovorin therapy for 56 patients with advanced recurrent colorectal carcinoma].
    Matsuda T; Ogino K; Hiroyoshi M; Fujita H; Itoh T; Toyama H; Kawai Y; Makita D; Tsunemi K; Moritomo H; Nakamura T
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):783-7. PubMed ID: 16770097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
    Link K; Happich K; Schirner I; Jüngert B; Brückl V; Männlein G; Brückl WM; Merkel S; Göhl J; Hohenberger W; Hahn EG; Wein A
    Anticancer Res; 2004; 24(1):385-91. PubMed ID: 15015625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer.
    Wein A; Riedel C; Brückl W; Merkel S; Ott R; Hanke B; Baum U; Fuchs F; Günther K; Reck T; Papadopoulos T; Hahn EG; Hohenberger W
    Oncology; 2003; 64(2):131-8. PubMed ID: 12566910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.
    Nobili S; Checcacci D; Filippelli F; Del Buono S; Mazzocchi V; Mazzei T; Mini E
    J Chemother; 2008 Oct; 20(5):622-31. PubMed ID: 19028627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
    Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
    Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients.
    Garufi C; Brienza S; Pugliese P; Aschelter AM; Bensmaine ; Bertheault-Cvitkovic F; Nisticò C; Giunta S; Caterino M; Giannarelli D; Cosimelli M; Lévi F; Terzoli E
    Anticancer Drugs; 2000 Jul; 11(6):495-501. PubMed ID: 11001391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
    Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil.
    Guglielmi A; Barni S; Zaniboni A; Pella N; Belvedere O; Beretta GD; Grossi F; Frontini L; Puglisi F; Labianca R; Sobrero A;
    Br J Cancer; 2004 Oct; 91(8):1428-33. PubMed ID: 15381935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II study.
    Kouroussis C; Souglakos J; Kakolyris S; Mavroudis D; Malamos N; Kalbakis K; Androulakis N; Agelaki A; Vardakis N; Samonis G; Georgoulias V
    Oncology; 2001; 61(1):36-41. PubMed ID: 11474246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX.
    Mori Y; Nishimura T; Kitano T; Yoshimura K; Matsumoto S; Kanai M; Hazama M; Ishiguro H; Nagayama S; Yanagihara K; Teramukai S; Chiba T; Sakai Y; Fukushima M
    Oncology; 2010; 79(1-2):136-43. PubMed ID: 21150228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine monotherapy as salvage treatment after failure of chemotherapy containing oxaliplatin and irinotecan in patients with metastatic colorectal cancer.
    Kim ST; Choi YJ; Park KH; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
    Asia Pac J Clin Oncol; 2011 Mar; 7(1):82-7. PubMed ID: 21332655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short-term effects of chemotherapy combined with hydroxycamptothecine and oxaliplatin in treatment of recurrent and metastatic colorectal cancer].
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC
    Ai Zheng; 2006 Aug; 25(8):1035-8. PubMed ID: 16965689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study.
    Santini D; Vincenzi B; Schiavon G; Di Seri M; Virzí V; Spalletta B; Caricato M; Coppola R; Tonini G
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):613-20. PubMed ID: 16944151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.